News
Search results
-
News -
News BIH Academy DCSP networking event „Forging the Digital Future”
-
News BIH Academy Call for applications for the new Translational Tandem Program (nTTP-GCT) is published!
The new funding line supports tandems of Junior Clinician Scientists and Translational Scientists interested in research with regard to their career, network and competence development in the GCT field.
-
News BIH Academy Review: Hot Topic Seminar “Virtual Reality in Mental Health”
-
News Insights into the human plasma proteome enable new therapeutic approaches
In a recently published study in Nature Metabolism, scientists have made important advances in understanding the biological influences on the human plasma proteome. The study was conducted by BIH Professor Claudia Langenberg and her team and analyzed data from 8,350 predominantly healthy, middle-aged men and women from the United Kingdom.
-
News ATiO Foundation partners with OARSI to fight osteoarthritis
The Advanced Therapies in Orthopaedics Foundation (ATiO) has recently announced an exciting new partnership with the Osteoarthritis Research Society International (OARSI). This collaboration brings together leading global experts from all professions in orthopaedics and osteoarthritis to foster innovation in advanced therapies for joint diseases.
-
News Charité BIH Innovation Lucid Genomics secures pre-seed funding of €1.3 million to fine-tune their AI models for the identification and diagnosis of biomarkers
The Berlin startup Lucid Genomics, a spin-off of the Max Planck Institute for Molecular Genetics and Charité - Universitätsmedizin Berlin, uses AI-based tools to decode previously undiscovered parts of human DNA. Founders Uirá Souto Melo and Hossein Moeinzadeh have now received 1.3 million euros in pre-seed funding to further develop their…
-
News How to select bacteria for environmental remediation
Researchers from the University of Lausanne and the Berlin Institute of Health at Charité (BIH) present a new sorting method to optimize the effect of bacterial communities for efficient degradation of environmental pollutants.
-
Press release On a mission to cure HIV: Christian Gaebler receives ERC Starting Grant
Prof. Christian Gaebler, an HIV researcher at Charité – Universitätsmedizin Berlin, has a goal: to develop treatments that cure HIV infection in patients or prompt the immune system to keep the virus in check in the long term, even without medications.